Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the BE series, reached its maximum allowed daily gain of 5.0%, moving from a low of Rs 1715.0 to a high of Rs 1805.4. This 5% price band capped the session’s upside, effectively freezing trading at the ceiling price. The upper circuit indicates that demand exceeded what the price band could accommodate, with no sellers willing to transact at lower levels. This unfilled demand is a hallmark of circuit hits, especially in micro-cap stocks like Venus Remedies Ltd, where liquidity constraints amplify the impact of such moves. What does the full demand picture look like for Venus Remedies once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Volume on the circuit day was 0.31825 lakh shares, translating to a turnover of ₹5.67 crore. While total traded volume is mechanically suppressed on circuit days due to the price lock, the delivery volume offers a clearer insight into the quality of the move. Delivery volume on 10 Jul was 1.91k shares but has fallen by 44.25% against the 5-day average, signalling a drop in long-term buying interest. This decline in delivery volume suggests that the upper circuit move may be driven more by speculative demand or thin liquidity rather than sustained accumulation. Is this a genuine buying conviction or a speculative spike given the falling delivery volumes?

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day. This positioning confirms a bullish trend that preceded the circuit event, with the upper circuit amplifying an already positive momentum. The stock has also been gaining for the last three consecutive days, delivering a cumulative return of 6.34% in that period. The weighted average price was closer to the low of the day, indicating that most volume traded near Rs 1715, before the price surged to the circuit limit. This intraday price action suggests a recovery from lower levels culminating in the circuit hit, rather than a steady climb throughout the session.

Liquidity and Market Capitalisation Context

With a market capitalisation of ₹2,413.28 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough for a trade size of approximately ₹0.19 crore based on 2% of the 5-day average traded value. While this liquidity is sufficient for retail and small institutional investors, it remains limited for larger trades, which can exacerbate price volatility and widen bid-ask spreads. This liquidity constraint is a critical factor to consider, as the upper circuit lock may partly reflect the thin order book typical of micro-cap stocks. With near-zero liquidity for larger trades, should investors be cautious about entering or exiting positions in Venus Remedies?

Intraday Price Action

The intraday range was relatively narrow, with the stock moving between Rs 1715.0 and Rs 1805.4. The weighted average price skewed towards the lower end, indicating that most volume was executed before the price surged to the circuit limit. This pattern is consistent with a late-session buying spree that pushed the stock to its ceiling. The circuit lock prevented any further upside, leaving buyers queued at Rs 1805.4 with no sellers willing to transact. Such a scenario often leads to pent-up demand that may spill over into subsequent sessions once the circuit restrictions lift.

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the stock’s recent price action is notable, the fundamental backdrop remains a key consideration for investors assessing the sustainability of the rally. The sector’s performance on the day was subdued, with the Pharmaceuticals & Biotechnology sector declining by 0.35% and the Sensex falling 0.26%, underscoring the stock’s relative outperformance.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1805.4 capped a 5.0% gain for Venus Remedies Ltd, reflecting strong buying interest that outpaced available supply. However, the decline in delivery volumes tempers the conviction narrative, suggesting that the move may be partly speculative or driven by thin liquidity rather than robust accumulation. The stock’s position above all major moving averages confirms an underlying bullish trend, but the micro-cap status and limited liquidity introduce significant risk for investors attempting to enter or exit sizeable positions. After a 5.0% single-day gain at upper circuit, is Venus Remedies still worth considering or has the move already happened?